Evidence map›Paper›PMID 39694898›Full record

ArticleAnnals of hematology2025

Angioimmunoblastic T-cell lymphoma harboring a t(8;14)(q24;q11.2)/TCR::MYC translocation that presented with intestinal infiltration.

Satoshi Ichikawa, Hiroki Kato, Naoya Morota, Hiroaki Abe, Akihisa Kawajiri, Kyoko Inokura, Koichi Onodera, Yasushi Onishi, Noriko Fukuhara, Satoko Sato and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Satoshi IchikawaDepartment of Hematology, Tohoku University Hospital, Sendai, Japan. ichikawa.satoshi@tohoku-mpu.ac.jp.
Hiroki KatoDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Naoya MorotaDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Hiroaki AbeDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Akihisa KawajiriDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Kyoko InokuraDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Koichi OnoderaDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Yasushi OnishiDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Noriko FukuharaDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.
Satoko SatoDepartment of Pathology, Tohoku University Hospital, Sendai, Japan.
Fumiyoshi FujishimaDepartment of Pathology, Tohoku University Hospital, Sendai, Japan.
Ryo IchinohasamaDepartment of Hematopathology, Tohoku University Hospital, Sendai, Japan.
Hideo HarigaeDepartment of Hematology, Tohoku University Hospital, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although rearrangement of the MYC oncogene (MYC-R) is frequently observed in aggressive B-cell lymphomas, it is extremely rare in T-cell malignancies. A 64-year-old man who had been under observation for several years because of asymptomatic pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALToma) was admitted to our hospital because of poor general condition and hypotension. Blood tests revealed thrombocytopenia and elevated serum lactate dehydrogenase levels, whereas computed tomography revealed systemic lymphadenopathy and splenomegaly. An inguinal lymph node biopsy precipitated a diagnosis of angioimmunoblastic T-cell lymphoma (AITL). Shortly after admission, the patient experienced spontaneous intestinal perforation and hemorrhage caused by multiple intestinal infiltrations of the AITL. Although chemotherapy was administered, the patient died several weeks after admission. A 46,XY,t(8;14)(q24;q11.2) karyotype was identified, and fluorescence in situ hybridization analyses showed split signals for the MYC and T-cell receptor (TCR) alpha genes, by which a TCR::MYC translocation was confirmed. Pathological autopsy analysis revealed systemic infiltration of the AITL and no MALToma lesions. Only a few cases of mature T-cell lymphoma harboring MYC-R have been reported in the literature thus far. To the best of our knowledge, this is the first reported case of AITL with TCR::MYC rearrangement. This condition could be associated with refractoriness to chemotherapy and aggressive clinical course with systemic infiltration that included the intestine.

Indexed as

Chromosomes, Human, Pair 14Chromosomes, Human, Pair 8Immunoblastic LymphadenopathyLymphoma, T-CellProto-Oncogene Proteins c-mycTranslocation, GeneticFatal OutcomeHumansMaleMiddle AgedProto-Oncogene Proteins c-mycAngioimmunoblastic T-cell lymphomaIntestinal infiltrationMYC oncogenePeripheral T-cell lymphomaTCR::MYC

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.